Strategy& Insider Episode 1 - Fighting cancer...

What does it take to get a life-changing medicine from regulatory approval to the patient who needs it? Isabell Remus, Global Head of Biosimilars at Sandoz, reveals why being approved and affordable isn't enough – and how the biosimilar industry learned that trust and education m ...  Show more

In this episode, Dr. Kahina Lang, Executive Director and Head of Next Gen Drug Delivery at Merck Group, discusses her pioneering work developing targeted mRNA delivery systems using lipid nanoparticle (LNP) technology. She shares insights on building an internal startup within th ...  Show more

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ...

In this episode, we sit down with Dr. Wael Hanna, thoracic surgeon and founder of NodeAI, a pioneering startup transforming the evaluation of mediastinal lymph nodes through artificial intelligence. Dr. Hanna shares the inspiration behind NodeAI, the clinical problem it aims t ...

Joel Bervell was one of the only Black students in his medical school program. After noticing how misconceptions about race were embedded in health care, he turned to social media to raise awareness about the harmful impact of biases in medicine. He unpacks the long history of ra ...  Show more

In this episode with Luna Maroun, Product Manager and Adobe, and previous start-up coach and teamlead at MIT, we explore the transformative rise of artificial intelligence in healthcare — from streamlining data collection to reshaping clinical decision-making. As AI tools beco ...